Aarti Pharmalabs Declares Interim Dividend of ₹1.50 Per Share; Record Date Set Today

Mumbai, February 16, 2026: Aarti Pharmalabs Limited has declared an interim dividend of ₹1.50 per equity share, representing 30% of the face value of ₹5 per share, for the financial year 2025–26.

The Board of Directors decided at its meeting held on Monday, February 9, 2026.

Key Dates and Timeline

In accordance with Regulation 42(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has fixed Monday, February 16, 2026, as the record date. This will determine the eligibility of shareholders entitled to receive the interim dividend.

Only those shareholders whose names appear in the Register of Members or in the records of Depositories as beneficial owners of the equity shares as of the record date will be eligible for the payout.

Aarti Pharmalabs Financials

For the quarter ended December 31, 2025, Aarti Pharmalabs reported standalone revenue from operations of Rs. 42,525.28 lakhs. After factoring in a loss of Rs. 37.12 lakhs from other income, the total standalone income for the period stood at Rs. 42,488.16 lakhs.

The company’s total expenses amounted to Rs. 36,350.58 lakhs, with the cost of materials consumed representing the largest expenditure at Rs. 20,985.41 lakhs.

The company recorded a standalone profit before tax of Rs. 5,858.10 lakhs, a figure that includes a deduction for exceptional items totaling Rs. 279.49 lakhs. Following a total tax expense of Rs. 1,473.64 lakhs, Aarti Pharmalabs achieved a net profit of Rs. 4,384.46 lakhs for the quarter.

Consequently, the basic earnings per share (EPS) for the period was Rs. 4.84, while the total comprehensive income was Rs. 4,447.47 lakhs.

Impact on Shareholders

The interim dividend of ₹1.50 per equity share will result in a cash payout to eligible shareholders. As this is a cash dividend, it does not alter the shareholding structure, equity capital, or ownership proportions of the company. There is no dilution impact associated with this corporate action.

Market Snapshot & Share Price Effect

As of 16 February 2026, 10:03 AM IST, on the NSE, Aarti Pharmalabs Ltd share price stood at ₹716.90, up ₹7.70 or 1.09% compared to the previous close of ₹709.20. The stock opened at ₹710.00 and traded within a high of ₹719.95 and low of ₹706.25 during the session.

The company has a market capitalisation of ₹6.50 thousand crore, with a P/E ratio of 30.40. It offers a dividend yield of 0.56%, with a quarterly dividend amount of ₹1.00 and over the past 52 weeks, the stock has recorded a high of ₹971.00 and a low of ₹574.45.

Ref:

•  https://www.nseindia.com/get-quote/equity/AARTIPHARM/Aarti-Pharmalabs-Limited
• https://nsearchives.nseindia.com/corporate/AARTIPHARMA_09022026202730_RecordDateIntimationFebruary092026signed.pdf
• https://nsearchives.nseindia.com/corporate/AARTIPHARMA_09022026200810_Outcomeofbmsigned.pdf